LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of The Chemours Company (“Chemours” or “the Company”) (NYSE: CC) for violations of the securities laws.
The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Chemours reported its financial results for the second quarter of 2024 on August 1, 2024. The Company’s earnings missed analyst estimates by a significant margin. The Company explained it "anticipates a low to mid-single digit sequential decline in Net Sales for the third quarter," based on "residual impacts from Q2 unplanned downtime at our Altamira, Mexico manufacturing site.” The Company added that "refrigerant seasonality paired with weaker Freon™ Refrigerants pricing in its Thermal & Specialized Solutions segment also contributed to its forecast. Based on this news, shares of Chemours fell by 11.88% on the same day.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
